Empery Asset Management’s BriaCell Therapeutics Corp Warrant BCTXZ Stock Holding History

Empery Asset Management’s Portfolio BCTXZ Stock Details BCTXZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93.3K	Hold	666,600	–	–	0.11%	22
2025 Q4	$193K	Buy	+666,600	New	+$248K	0.17%	18

Other funds holding BCTXZ

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Empery Asset Management's BCTXZ Position: Q1 2026 in Review

Empery Asset Management held its BriaCell Therapeutics Corp Warrant (BCTXZ) position steady in Q1 2026 at 666,600 shares worth $93.3K. The position accounts for 0.11% of the portfolio, ranked #22.

Empery Asset Management first reported a position in BCTXZ in Q4 2025 and has held it in 2 quarters since. The position peaked at $193K in Q4 2025. 4 funds tracked by Wall St. Rank hold BCTXZ as of Q1 2026.

Empery Asset Management held 666,600 shares of BriaCell Therapeutics Corp Warrant worth $93.3K as of Q1 2026.
Empery Asset Management left its BriaCell Therapeutics Corp Warrant share count unchanged in Q1 2026.
BriaCell Therapeutics Corp Warrant made up 0.11% of Empery Asset Management's portfolio in Q1 2026, its #22 holding.
Empery Asset Management first reported a position in BriaCell Therapeutics Corp Warrant in Q4 2025 and has held it in 2 quarters since.
Empery Asset Management's BriaCell Therapeutics Corp Warrant position peaked at $193K in Q4 2025.
4 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2026.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.